Literature DB >> 19933442

Relationship of exposure to clinically irrelevant emotion cues and obsessive-compulsive symptoms.

Laura B Allen1, David H Barlow.   

Abstract

Research has highlighted the role of emotion regulation as a common factor underlying emotional disorders. The current study examined the relationship of emotion regulation skills to obsessive-compulsive disorder (OCD) symptoms. Seven participants with a principal diagnosis of OCD in a multiple-baseline across subjects design were taught the skill of prevention of emotional avoidance in the context of emotion provocation procedures to clinically irrelevant (nonspecific) cues prior to practicing this skill with clinically relevant (OCD-specific) cues. Results suggested successful acquisition of emotion regulation skills (as evidenced by decreased thought suppression and increased acceptance of thoughts and feelings) in clinically irrelevant contexts. Acquisition of this skill was associated with decreases in obsessive-compulsive symptoms, even though clinically relevant cues were not introduced during this phase. Implementation of skills in clinically relevant contexts was associated with greater reductions in OCD symptoms. Discussion focuses on implications for emotion regulatory processes in the maintenance and treatment of emotional disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19933442     DOI: 10.1177/0145445509344180

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  2 in total

1.  Anger Rumination is not Uniquely Characteristic of Obsessive-Compulsive Disorder.

Authors:  Sarah C Jessup; Kelly A Knowles; Hannah Berg; Bunmi O Olatunji
Journal:  Pers Individ Dif       Date:  2018-09-12

2.  Anger and aggressiveness in obsessive-compulsive disorder (OCD) and the mediating role of responsibility, non-acceptance of emotions, and social desirability.

Authors:  Barbara Cludius; Anna K Mannsfeld; Alexander F Schmidt; Lena Jelinek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-05       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.